Halozyme Therapeutics Inc (HALO) financials · rev $1.40B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Halozyme Therapeutics Inc (HALO) rev $1.40B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.40B | $1.02B |
| Cost of Revenue | $228.8M | $159.4M |
| Gross Profit | $1.17B | $855.9M |
| Operating Income | $469.0M | $551.5M |
| Net Income | $316.9M | $444.1M |
| EPS (Diluted) | $2.56 | $3.43 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $2.53B | $2.06B |
| Current Assets | $825.2M | $1.09B |
| Cash & Equivalents | $133.8M | $115.8M |
| Inventory | $176.5M | $141.9M |
| PP&E | $44.4M | $40.9M |
| Total Liabilities | $2.48B | $1.70B |
| Current Liabilities | $177.1M | $139.1M |
| Short-term Debt | N/A | N/A |
| Long-term Debt | $2.14B | $1.51B |
| Total Debt | $2.14B† | $1.51B† |
| Shareholders' Equity | $48.8M | $363.8M |
| Retained Earnings | $54.8M | $359.9M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $651.6M | $479.1M |
| CapEx | $6.97M | $10.7M |
| Investing Cash Flow | -$545.8M | -$262.7M |
| Financing Cash Flow | -$85.2M | -$218.9M |
| Net Change in Cash | $20.6M | -$2.52M |
| Free Cash Flow | $644.6M | $468.4M |
FAQ
What is HALO P/E and revenue?
Halozyme Therapeutics Inc (HALO) rev $1.40B.
What is HALO revenue?
Halozyme Therapeutics Inc last cached revenue is $1.40B (FY2025).
Is HALO profitable?
Halozyme Therapeutics Inc last cached net income is $316.9M (FY2025).
What are HALO total assets?
Halozyme Therapeutics Inc last cached total assets are $2.53B (FY2025).
What is HALO free cash flow?
Halozyme Therapeutics Inc last cached free cash flow is $644.6M (FY2025).
Not investment advice. Cached statements, not a live tape.